Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
about
The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancerNew aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cellsNon-steroidal anti-inflammatory drugs decrease E2F1 expression and inhibit cell growth in ovarian cancer cellsProstaglandins in cancer cell adhesion, migration, and invasionHydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.Antiproliferative effects of aspirin and diclofenac against the growth of cancer and fibroblast cells: In vitro comparative study.Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines.Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools.Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators.New sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors.The effect of oxamflatin on the E-cadherin expression in gastric cancer cell line.Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.Diclofenac-Based Hydrazones and Spirothiazolidinones: Synthesis, Characterization, and Antimicrobial Properties.
P2860
Q28387891-0040DC56-C78A-4DC8-A15D-19EAEF15BD19Q28534587-B2461991-EEB4-4A16-A273-CC520FE46A27Q34700681-562D44E6-CC4E-4411-BE25-DB7E67573681Q35821653-D4EE25D8-59E7-48B7-86D1-188D97A71355Q36025402-07B8F029-E718-4D4E-926B-136069542176Q36162030-4150B242-3F09-4F94-87F7-83881C8003FDQ36242634-14131AA0-8064-4247-AF69-E912CC19C5C7Q37110658-E18EF765-70CE-4DDD-89AB-3E78722158E1Q37917815-07B296B5-E90E-4D52-9E8F-8DD44A91CBDFQ37960620-6DB1D8F9-A2C3-4F1A-8DB2-1DB2AD0649ADQ38696518-42949D06-4F8B-48F6-8117-235ACCE0AA61Q38739161-70AA3B7C-5A75-4A89-B704-F0A1FF2625DEQ39418780-51DA3A5B-7953-4561-82CF-39849D8799B1Q40261310-7B1444D5-5FE2-4114-B082-FCA09926CA7A
P2860
Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dithiolethione modified valpro ...... -small cell lung cancer cells.
@en
Dithiolethione modified valpro ...... -small cell lung cancer cells.
@nl
type
label
Dithiolethione modified valpro ...... -small cell lung cancer cells.
@en
Dithiolethione modified valpro ...... -small cell lung cancer cells.
@nl
prefLabel
Dithiolethione modified valpro ...... -small cell lung cancer cells.
@en
Dithiolethione modified valpro ...... -small cell lung cancer cells.
@nl
P2093
P2860
P50
P1433
P1476
Dithiolethione modified valpro ...... n-small cell lung cancer cells
@en
P2093
Christopher Switzer
David A Wink
Grace C Yeh
Lisa A Ridnour
Marc Berna
Michelle Thill
Piero Del Soldato
Robert T Jensen
Terry W Moody
Wilmarie Santana-Flores
P2860
P304
P356
10.1016/J.LUNGCAN.2009.06.012
P577
2009-07-23T00:00:00Z